Liu Xing-Hong, Zou Jiao, Li Yan-Jun, Liu Man, He Cui-Lin, Liu You-Ran, Wang Jian-Zhong, Chen Dong-Lin
Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.
Steroids. 2021 Dec;176:108929. doi: 10.1016/j.steroids.2021.108929. Epub 2021 Oct 12.
One new cevanine isosteroidal alkaloid named 5,6-anhydrohupehenine (1), together with five known alkaloids (2-6) were isolated from Fritillaria hupehensis Hsiao et K.C.Hsia, among which 5,6-anhydrohupehenine (1) exhibited strong inhibitory activity against HepG2 (IC = 12.21 μM) and MCF-7 (IC = 22.05 μM) cancer cells. Therefore, a total of 33 5,6-anhydrohupehenine derivatives (9a-9s, 10a-10f, 11a-11b, and 12a-12f) were synthesized and evaluated for their cytotoxic activity. The cytotoxicity evaluation of all 5,6-anhydrohupehenine derivatives against HepG2 and MCF-7 human cancer cells revealed that 9s displayed best activity against HepG2 cells with IC at 1.27 μM. Further biological evaluations on 9s showed that it inhibited the proliferation of HepG2 cells and induced apoptosis of the HepG2 cells by activating cleaved caspase-3. Moreover, 9s exhibited strong antimetastatic potential. These results suggest that 5,6-anhydrohupehenine is a promising compound to be designed as novel cytotoxic agents.
从湖北贝母中分离得到一种新的瑟文类甾体生物碱5,6-脱水湖北贝母碱(1)以及五种已知生物碱(2 - 6),其中5,6-脱水湖北贝母碱(1)对肝癌细胞HepG2(IC = 12.21 μM)和乳腺癌细胞MCF-7(IC = 22.05 μM)表现出较强的抑制活性。因此,合成了总共33种5,6-脱水湖北贝母碱衍生物(9a - 9s、10a - 10f、11a - 11b和12a - 12f)并评估了它们的细胞毒性活性。所有5,6-脱水湖北贝母碱衍生物对HepG2和MCF-7人癌细胞的细胞毒性评估显示,9s对HepG2细胞表现出最佳活性,IC为1.27 μM。对9s的进一步生物学评估表明,它抑制HepG2细胞的增殖并通过激活裂解的半胱天冬酶-3诱导HepG2细胞凋亡。此外,9s表现出很强的抗转移潜力。这些结果表明,5,6-脱水湖北贝母碱是一种有前景的化合物,可被设计为新型细胞毒性药物。